Stockscreener 앱 받기
47.32
3.41%
-1.67
전일 마감가:
$48.99
열려 있는:
$49.04
하루 거래량:
626.51K
Relative Volume:
0.46
시가총액:
$5.67B
수익:
$47.30M
순이익/손실:
$-408.73M
주가수익비율:
-13.19
EPS:
-3.5865
순현금흐름:
$-303.86M
1주 성능:
-0.73%
1개월 성능:
-13.96%
6개월 성능:
+6.72%
1년 성능:
+27.72%
1일 변동 폭
$46.92
$49.33
1주일 범위
$46.92
$50.12
52주 변동 폭
$27.07
$58.49
Scholar Rock Holding Corp Stock (SRRK) Company Profile
명칭
Scholar Rock Holding Corp
전화
857-259-3860
주소
301 BINNEY STREET, CAMBRIDGE, MA
Compare SRRK vs VRTX, REGN, ARGX, RVMD, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SRRK
Scholar Rock Holding Corp
|
47.32 | 5.86B | 47.30M | -408.73M | -303.86M | -3.5865 |
VRTX
Vertex Pharmaceuticals Inc
|
477.10 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
762.63 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
853.82 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
187.53 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
316.01 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Scholar Rock Holding Corp Stock (SRRK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-21 | 개시 | Canaccord Genuity | Buy |
| 2026-01-09 | 개시 | Citigroup | Buy |
| 2025-11-18 | 개시 | Wolfe Research | Outperform |
| 2025-10-09 | 개시 | BofA Securities | Buy |
| 2025-09-17 | 개시 | Barclays | Overweight |
| 2025-09-15 | 개시 | Leerink Partners | Outperform |
| 2025-08-21 | 재개 | Jefferies | Buy |
| 2025-07-30 | 재개 | Raymond James | Strong Buy |
| 2025-07-17 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-11-26 | 재확인 | H.C. Wainwright | Buy |
| 2024-10-07 | 재확인 | H.C. Wainwright | Buy |
| 2024-03-28 | 개시 | Raymond James | Strong Buy |
| 2023-10-25 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-04-03 | 재개 | Piper Sandler | Overweight |
| 2022-09-19 | 재개 | H.C. Wainwright | Buy |
| 2022-07-12 | 개시 | Truist | Buy |
| 2022-03-23 | 개시 | H.C. Wainwright | Buy |
| 2021-12-22 | 다운그레이드 | Jefferies | Buy → Hold |
| 2021-11-19 | 개시 | Piper Sandler | Overweight |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2021-01-11 | 개시 | Credit Suisse | Outperform |
| 2021-01-06 | 개시 | JP Morgan | Overweight |
| 2020-03-12 | 개시 | Robert W. Baird | Outperform |
모두보기
Scholar Rock Holding Corp 주식(SRRK)의 최신 뉴스
Scholar Rock Holding Corporation $SRRK Shares Bought by Eagle Health Investments LP - MarketBeat
Scholar Rock stock advances on buying interest after oversold momentum and technical recovery - Traders Union
Scholar Rock Holding Corp (SRRK) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Scholar Rock Holding Corp (SRRK) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
SRRK|Scholar Rock Holding Corp|Price:48.930|Chg%:+1.260 - TradingKey
Scholar Rock Holding Corp (SRRK) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Scholar Rock Holding Corp (SRRK) Cash Flow - TradingKey
SRRK|Scholar Rock Holding Corp|Price:49.820|Chg%:+2.150 - TradingKey
SRRK|Scholar Rock Holding Corp|Price:47.750|Chg%:-1.180 - TradingKey
Scholar Rock Holding Corp (SRRK) Balance Sheet - TradingKey
TradingKey - TradingKey
Scholar Rock Holding Corporation (NASDAQ:SRRK) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
SRRK|Scholar Rock Holding Corp|Price:47.670|Chg%:-1.810 - TradingKey
ETFs Investing in Scholar Rock Holding Corp. Stocks - TradingView
Scholar Rock Holding Corp (SRRK) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
D.A. Davidson & CO. Purchases New Position in Scholar Rock Holding Corporation $SRRK - MarketBeat
SRRK Stock Surges To Near Five-Year Highs – Here’s Why Analysts Are Bullish About Its Latest FDA Filing - Stocktwits
SRRK Reiterated by Wedbush -- Price Target Maintained at $58 - GuruFocus
Scholar Rock says EU opinion on SMA drug may be pushed to later in 2026 - Reuters
Scholar Rock (NASDAQ:SRRK) Receives Outperform Rating from Wedbush - MarketBeat
Scholar Rock Holding Corporation (SRRK): Investor Outlook with a Promising 17.08% Upside - DirectorsTalk Interviews
Law firm investigates Scholar Rock officers for possible shareholder duty breaches - Pluang
Scholar Rock awaits FDA decision on apitegromab EU approval By Investing.com - Investing.com Nigeria
Scholar Rock awaits FDA decision on apitegromab EU approval - Investing.com India
SMA treatment review in Europe awaits FDA facility classification - Stock Titan
Scholar Rock Provides Update on Timing of Committee for Medicinal Products for Human Use (CHMP) Opinion for Apitegromab Marketing Authorisation Application (MAA) for Spinal Muscular Atrophy (SMA) - Yahoo Finance
Jennison Associates LLC Buys 545,304 Shares of Scholar Rock Holding Corporation $SRRK - MarketBeat
11 New Hires Get Scholar Rock Equity Awards Covering 118,586 Shares - Stock Titan
Scholar Rock (SRRK) Goldman Sachs 47th Annual Global Healthcare Conference 2026 summary - Quartr
Scholar Rock (SRRK) Q3 2025 earnings summary - Quartr
Scholar Rock schedules Aug. 6 webcast before markets open - Stock Titan
Biotech Stocks At 52-Week Highs: AMWL, CUE, ICCC, SRRK, FTH - RTTNews
Scholar Rock Holding Corporation $SRRK Holdings Raised by Candriam S.C.A. - MarketBeat
SRRK Stock Prediction: Huge SMA Drug Launch Breakthrough? (2026 Alert) Marcus Smart (7wRYet6o9c) - Mshale
Scholar Rock Holding (SRRK) Rallies As Pipeline Story Meets A Fair Value Question - simplywall.st
SG Americas Securities LLC Cuts Stake in Scholar Rock Holding Corporation $SRRK - MarketBeat
Scholar Rock (SRRK) Q1 2025 earnings summary - Quartr
Inside THNR: A Leaner Approach to Weight Loss Investing - ETF Database
Scholar Rock stock hits 52-week high at 56.56 USD By Investing.com - Investing.com Canada
Scholar Rock stock hits 52-week high at 56.56 USD - Investing.com
Form 144 Scholar Rock Holding Corp. For: 6 July By Investing.com - Investing.com Canada
Scholar Rock (NASDAQ: SRRK) director 10b5-1 sale of 3,053 shares - Stock Titan
Scholar Rock (SRRK) director’s 3,053-share sale tied to RSU tax obligations - Stock Titan
Scholar Rock (SRRK) director Katie Peng sells 5,446 shares under 10b5-1 tax plan - Stock Titan
Mohammed Qatanani to sell 11,704 SRRK shares (NASDAQ: SRRK) - Stock Titan
SRRKScholar Rock Holding Corp Volatility & Greeks - Finviz
[144] Scholar Rock Holding Corp SEC Filing - Stock Titan
Form 144 Scholar Rock Holding Corp. For: 1 July By Investing.com - Investing.com India
SRRK (NASDAQ: SRRK) files Rule 144 notice to sell 5,446 shares via J.P. Morgan - Stock Titan
Pictet Asset Management Holding SA Cuts Stake in Scholar Rock Holding Corporation $SRRK - MarketBeat
Scholar Rock Holding Corporation (NASDAQ:SRRK) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Scholar Rock Holding Corp (SRRK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Scholar Rock Holding Corp 주식 (SRRK) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Gilman Michael | Director |
Jul 01 '26 |
Sale |
53.87 |
2,544 |
137,058 |
59,511 |
| Burow Kristina | Director |
Jul 01 '26 |
Sale |
53.74 |
3,053 |
164,064 |
114,657 |
| Reed Joshua | Director |
Jul 01 '26 |
Sale |
53.74 |
3,053 |
164,067 |
19,518 |
| Peng Katie | Director |
Jul 01 '26 |
Sale |
53.88 |
5,446 |
293,405 |
34,301 |
2.44%
0.02%
자본화:
|
볼륨(24시간):